A 3D View: Exploring the Patient Centric Approach to Biomarker Driven Therapy for Patients with Severe Asthma
Program Chair and Faculty
Michael Wechsler, MD, MMSc
Director, Asthma Program
Professor of Medicine
Division of Pulmonary, Critical Care & Sleep Medicine
Department of Medicine
National Jewish Health
This 3D case-based enduring activity will cover the diagnosis, treatment and management of patients with severe asthma.
This CME initiative is designed to meet the educational needs of pulmonologists, internists, pediatricians, registered nurses, and other healthcare providers involved in the treatment of patients with eosinophilic asthma.
After completing the CME activity, attendees should be able to:
- Discuss the molecular biology underlying the inflammation of asthma and associated therapeutic targets
- Assess patients’ level of control, severity of disease, and exacerbation risk in the management of asthma
- Describe the clinical trial data of current and emerging antibody targeted therapies and potential biomarkers for patients with moderate-to-severe asthma
ACCREDITATION AND DESIGNATION STATEMENT
National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
National Jewish Health designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Provider approved by the California Board of Registered Nursing, Provider Number 12724, for 1.2 contact hours.
DISCLOSURE POLICY STATEMENT
As a sponsor accredited by the Accreditation Council for Continuing Medical Education (ACCME), National Jewish Health is dedicated to providing continuing medical education that is independent, fair, balanced, objective and free of commercial bias. The Office of Professional Education and the Continuing Medical Education (CME) committee at National Jewish Health require that all scientific session faculty comply with all applicable laws and regulations governing disclosure. All financial interests or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services must be disclosed.
DISCLOSURE OF FINANCIAL RELATIONSHIPS
Dr. Wechsler discloses he is a consultant and has received honoraria from GlaxoSmithKline, Boston Scientific, Teva, Boehringer Ingelheim, Novartis, Vectura, Theravance, Sanofi/Regeneron, and Astrazeneca. He is an investigator for Sanofi/Regeneron and AstraZeneca. He has received a grant from Sanofi/Regeneron.
The independent reviewers, staff, planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests:
Anthony Gerber, MD, PhD
Department of Medicine
Division of Pulmonary, Critical Care and Sleep Medicine
Department of Biomedical Research
National Jewish Health
Dr. Gerber discloses he is a consultant for Revon Systems.
CNE Content Review
Allidah Poole Hicks, RN, MS, AE-C
Staff Development RN
National Jewish Health
Ms. Hicks has no financial relationships to disclose.
Staff, Planners and Managers
Matthew Frese, General Manager of Med Learning Group has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group has nothing to disclose.
Lauren Welch, MA, VP, Outcomes and Accreditation for Med Learning Group has nothing to disclose.
Brooke Hefele, Outcomes Coordinator for Med Learning Group has nothing to disclose.
Kathleen Krafton, Medical Director, Scientific and Medical Services for Med Learning Group has nothing to disclose.
Lisa Dorin, Senior Program Manager for Med Learning Group has nothing to disclose.
Sarah K. Meadows, MS, CHCP, Manager, Accreditation and Programs, Office of Professional Education for National Jewish Health has nothing to disclose.
DISCLOSURE OF UNLABELED USE
National Jewish Health and Med Learning Group require that faculty participating in any CME/CNE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During the course of this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME/CNE credit participants must:
1. Read the CME/CNE information and faculty disclosures.
2. Participate in the enduring activity.
3. Submit the evaluation form to the Med Learning Group.
You will receive your certificate via email within 30 days.
For CME questions, please contact: Med Learning Group at firstname.lastname@example.org.
For questions about the CME or CNE certification of this activity, please contact: The Office of Professional Education at National Jewish Health at email@example.com
National Jewish Health (“NJH”) and its officers, Board of Directors, faculty, employees, representatives, and other agents (collectively, “NJH Parties”) shall not be responsible in any capacity for, and do not warrant any content whatsoever, in any NJH publication or other product (in any medium), or the use or reliance on any such content, and expressly disclaim any and all liability for such content. All such responsibility for content and use of product solely rests with the authors or the advertisers, as the case may be.
By way of example, without limiting the foregoing, this disclaimer of liability applies to the accuracy, completeness, effectiveness, quality, appearance, ideas, or products, as the case may be, of or resulting from, any statements, references, articles, positions, claimed diagnosis, claimed possible treatments, services, or advertising, express or implied, contained in any NJH enduring meeting, publication, online course or other product.
Furthermore, the content should not be considered medical advice and is not intended to replace consultation with a qualified medical professional. Under no circumstances, including negligence, shall any of the NJH Parties be liable for any DIRECT, INDIRECT, INCIDENTAL, SPECIAL or CONSEQUENTIAL DAMAGES, or LOST PROFITS that result from any of the foregoing, regardless of legal theory and whether or not claimant was advised of the possibility of such damages.
RELEASE DATE: December 6, 2017
EXPIRATION DATE: December 6, 2018
This educational activity provides training necessary for licensed attendees to maintain state licensing requirements. The tuition for this educational activity is subsidized in part by unrestricted educational grants, including for those attendees who have successfully completed the state licensing requirements for their respective fields. This subsidy is reflected in the registration fees for this activity.
Copyright © 2017 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.